Results 201 to 210 of about 1,302,201 (345)

Interactions Between Active Matters and Endogenous Fields

open access: yesAdvanced Materials, EarlyView.
This review synthesizes endogenous field information and computational methods in contexts such as cancer, wounds, and biofilms. It organizes NAMs and AAMs by sensing, transmitting, and executing functions, compares their limitations, and from these contrasts proposes design strategies for next‐generation AAMs, offering perspectives to foster ...
Jinwei Lin   +6 more
wiley   +1 more source

Reconciling differences in impact of molecular subtyping on response to cisplatin-based chemotherapy

open access: yesNature Communications, 2021
Mathieu Roumiguie   +3 more
doaj   +1 more source

DNA-Repair Defects and Olaparib in Metastatic Prostate Cancer.

open access: yesNew England Journal of Medicine, 2015
J. Mateo   +50 more
semanticscholar   +1 more source

Peptide Amphiphiles Hitchhike on Endogenous Biomolecules for Enhanced Cancer Imaging and Therapy

open access: yesAdvanced Materials, EarlyView.
Weakly assembled peptide amphiphile nanostructures disassemble in circulation and reassemble with blood biomolecules, mainly lipoproteins. Binding to blood biomolecules prolongs blood circulation and improves accumulation in solid tumors. In the tumor microenvironment, peptide amphiphiles assemble with cholesterol‐rich domains of cell membranes ...
Li Xiang   +19 more
wiley   +1 more source

Evaluation of a prostate SBRT planning workflow using auto-segmentation and knowledge-based planning. [PDF]

open access: yesJ Appl Clin Med Phys
Jones T   +7 more
europepmc   +1 more source

Inherited DNA-Repair Gene Mutations in Men with Metastatic Prostate Cancer.

open access: yesNew England Journal of Medicine, 2016
C. Pritchard   +45 more
semanticscholar   +1 more source

Advances and Strategies in Enhancing mRNA Cancer Vaccines

open access: yesAdvanced Materials, EarlyView.
Messenger RNA (mRNA) vaccines offer a powerful approach for cancer immunotherapy, but their clinical impact remains limited by delivery challenges and suboptimal immune activation. This review discusses key biological barriers and design strategies—including structural optimization, immunomodulation, organ targeting delivery, and advanced nanocarriers ...
Miao Zhang   +4 more
wiley   +1 more source

Home - About - Disclaimer - Privacy